Maarten C.C.M. Hulshof

19.6k citations

225 papers · 6.0k indexed · 4 hit papers · h-index 38

Pulmonary and Respiratory Medicine top 0.5%
Surgery top 0.5%
Radiology, Nuclear Medicine and Imaging top 1%
Oncology top 2%
Biomedical Engineering top 2%

Co-authors: Mark I. van Berge Henegouwen Dionisio González Hanneke W.M. van Laarhoven Jens Overgaard Giorgio Arcangeli Søren M. Bentzen Arjan Bel George van Andel
Topics: Esophageal Cancer Research and Treatment (95 papers)Gastric Cancer Management and Outcomes (69 papers)Lung Cancer Diagnosis and Treatment (41 papers)
Cited by: Pulmonary and Respiratory Medicine Radiation Surgery
Journals: Proceedings of the National Academy of Sciences The Lancet Journal of Clinical Oncology
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Maarten C.C.M. Hulshof

221 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma

1995 444 citations Maarten C.C.M. Hulshof et al. profile →
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

2014 340 citations Vera Oppedijk, J. Jan B. van Lanschot et al. profile →
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial

2018 336 citations Liselotte M.S. Boevé, Maarten C.C.M. Hulshof et al. European Urology profile →
Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

2021 167 citations Maarten C.C.M. Hulshof, Elisabeth D. Geijsen et al. profile →

Peers

Countries citing papers authored by Maarten C.C.M. Hulshof

Since Specialization

Citations

This map shows the geographic impact of Maarten C.C.M. Hulshof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten C.C.M. Hulshof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten C.C.M. Hulshof more than expected).

Fields of papers citing papers by Maarten C.C.M. Hulshof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten C.C.M. Hulshof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten C.C.M. Hulshof. The network helps show where Maarten C.C.M. Hulshof may publish in the future.

Co-authorship network of co-authors of Maarten C.C.M. Hulshof

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten C.C.M. Hulshof. A scholar is included among the top collaborators of Maarten C.C.M. Hulshof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten C.C.M. Hulshof. Maarten C.C.M. Hulshof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prostate Cancer–related Events in Patients with Synchronous Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate; Data from the HORRAD Trial 2024 ·European Urology ·Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,Paul C.M.S. Verhagen,Jos W. R. Twisk,Wim P.J. Witjes,Peter de Vries,R. Jeroen A. van Moorselaar,André N. Vis,George van Andel	2
2	Genome‐wide and panel‐based cell‐free DNA characterization of patients with resectable esophageal adenocarcinoma 2023 ·The Journal of Pathology ·Tom van den Ende,Ymke van der Pol,Aafke Creemers,Norbert Moldován,(unknown),Mark I. van Berge Henegouwen,Maarten C.C.M. Hulshof,Saskia A.G.M. Cillessen,Nicole C.T. van Grieken,D. Michiel Pegtel,Sarah Derks,Maarten F. Bijlsma,Florent Moulière,Hanneke W. M. van Laarhoven	3
3	Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure 2023 ·ESMO Open ·Erica Feldman,Floris J. Pos,Robert Jan Smeenk,Henk G. van der Poel,Pim van Leeuwen,Jeantine M. de Feijter,Maarten C.C.M. Hulshof,Tom Budiharto,Rosella Hermens,Kelly M. de Ligt,Iris Walraven	7
4	Treatment decision‐making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study 2022 ·Cancer Medicine ·(unknown),Linda Brom,Pauline A. J. Vissers,(unknown),Fabienne Warmerdam,Joos Heisterkamp,Stella Mook,(unknown),Marc J. van Det,(unknown),Maarten C.C.M. Hulshof,Hanneke W.M. van Laarhoven,Camiel Rosman,Peter D. Siersema,Marjan J. Westerman,Rob H.A. Verhoeven,Grard A. P. Nieuwenhuijzen	1
5	A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases 2022 ·European Journal of Surgical Oncology ·Willemieke P.M. Dijksterhuis,Tiuri E. Kroese,Rob H.A. Verhoeven,Peter S.N. van Rossum,Stella Mook,Nadia Haj Mohammad,Maarten C.C.M. Hulshof,Suzanne S. Gisbertz,Jelle P. Ruurda,Martijn G.H. van Oijen,Richard van Hillegersberg,Hanneke W.M. van Laarhoven	4
6	Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison 2022 ·British journal of surgery ·Ben M. Eyck,Xing Gao,Yang Yang,Berend J. van der Wilk,Yhi Wong,Bas P. L. Wijnhoven,Jun Liu,Sjoerd M. Lagarde,(unknown),Maarten C.C.M. Hulshof,Zhigang Li,Simon Law,Yin‐Kai Chao,J. Jan B. van Lanschot,(unknown),(unknown)	11
7	Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia 2022 ·Acta Oncologica ·Paul M. Jeene,(unknown),Héctor G. van den Boorn,Sherif Y. El Sharouni,Pètra M. Braam,Vera Oppedijk,Rob H.A. Verhoeven,Maarten C.C.M. Hulshof,Hanneke W. M. van Laarhoven	1
8	Improved Clinical and Survival Outcomes After Esophagectomy for Cancer Over 25 Years 2022 ·The Annals of Thoracic Surgery ·Annelijn E. Slaman,Giovanni Pirozzolo,Wietse J. Eshuis,Jacques Bergman,Maarten C.C.M. Hulshof,Hanneke W.M. van Laarhoven,Sybren L. Meijer,Suzanne S. Gisbertz,Mark I. van Berge Henegouwen	11
9	Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer 2022 ·European Urology ·(unknown),(unknown),(unknown),Theo M. de Reijke,R. Jeroen A. van Moorselaar,(unknown),(unknown),Mila Donker,Tom van der Hulle,Jens Voortman,Jorg R. Oddens,Maarten C.C.M. Hulshof,Adriaan D. Bins	18
10	Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP) 2021 ·Annals of Surgical Oncology ·(unknown),Mark I. van Berge Henegouwen,Hanneke W.M. van Laarhoven,Jessy Joy van Kleef,Wietse J. Eshuis,Joos Heisterkamp,H.H. Hartgrink,Camiel Rosman,Richard van Hillegersberg,Maarten C.C.M. Hulshof,Mirjam A. G. Sprangers,Suzanne S. Gisbertz,(unknown)	19
11	Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis 2020 ·Critical Reviews in Oncology/Hematology ·Héctor G. van den Boorn,(unknown),Aeilko H. Zwinderman,Wietse J. Eshuis,Maarten C.C.M. Hulshof,Faridi S. van Etten‐Jamaludin,Mirjam A. G. Sprangers,Hanneke W.M. van Laarhoven	37
12	Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial 2020 ·European Urology ·Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,Paul C.M.S. Verhagen,Jos W. R. Twisk,Wim P.J. Witjes,Peter de Vries,R. Jeroen A. van Moorselaar,George van Andel,André N. Vis	23
13	Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer 2018 ·Acta Oncologica ·Ruben T. H. M. Larue,Remy Klaassen,Arthur Jochems,Ralph T. H. Leijenaar,Maarten C.C.M. Hulshof,Mark I. van Berge Henegouwen,Wendy Schreurs,Meindert N. Sosef,Wouter van Elmpt,Hanneke W.M. van Laarhoven,Philippe Lambin	61
14	A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas 2018 ·Scientific Reports ·Aafke Creemers,Eva A. Ebbing,Thomas Pelgrim,Sjoerd M. Lagarde,Faridi S. van Etten‐Jamaludin,Mark I. van Berge Henegouwen,Maarten C.C.M. Hulshof,Kausilia K. Krishnadath,Sybren L. Meijer,Maarten F. Bijlsma,Martijn G.H. van Oijen,Hanneke W.M. van Laarhoven	25
15	Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling 2016 ·Medical Physics ·(unknown),H. Petra Kok,(unknown),Elisabeth D. Geijsen,(unknown),Jan Sijbrands,A. Bakker,Jean de la Rosette,Maarten C.C.M. Hulshof,Theo M. de Reijke,Johannes Crezee	17
16	Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients 2016 ·Radiation Oncology ·(unknown),Rob M. van Os,Arjan Bel,Maarten C.C.M. Hulshof	26
17	Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction 2016 ·Annals of Surgery ·Maarten Anderegg,Sjoerd M. Lagarde,(unknown),Suzanne S. Gisbertz,Arul Immanuel,Sybren L. Meijer,Maarten C.C.M. Hulshof,Jacques Bergman,Hanneke W.M. van Laarhoven,S M Griffin,Mark I. van Berge Henegouwen	30
18	Preoperative Chemoradiation Therapy in Combination With Panitumumab for Patients With Resectable Esophageal Cancer: The PACT Study 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Sil Kordes,Mark I. van Berge Henegouwen,Maarten C.C.M. Hulshof,Jacques Bergman,Hans van Vliet,Ellen Kapiteijn,Hanneke W.M. van Laarhoven,Dick J. Richel,Jean H. G. Klinkenbijl,Sybren L. Meijer,Johanna W. Wilmink	23
19	Fusion of planning CT and cystoscopy images for bladder tumor delineation: A feasibility study 2013 ·Medical Physics ·(unknown),Floris J. Pos,A. Betgen,Axel Bex,Maarten C.C.M. Hulshof,P. Remeijer,Marcel van Herk	4
20	Semiautomatic bladder segmentation on CBCT using a population-based model for multiple-plan ART of bladder cancer 2012 ·Physics in Medicine and Biology ·Xiangfei Chai,Marcel van Herk,A. Betgen,Maarten C.C.M. Hulshof,Arjan Bel	5

About Maarten C.C.M. Hulshof

Maarten C.C.M. Hulshof is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Surgery, having authored 225 papers that have together received 6.0k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (95 papers), Gastric Cancer Management and Outcomes (69 papers) and Lung Cancer Diagnosis and Treatment (41 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.2k citations), Radiation (802 citations) and Surgery (3.0k citations). Maarten C.C.M. Hulshof has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Mark I. van Berge Henegouwen, Dionisio González, Hanneke W.M. van Laarhoven, Jens Overgaard, Giorgio Arcangeli, Søren M. Bentzen, Arjan Bel, George van Andel, Ate van der Gaast and Floris J. Pos. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact